BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12907722)

  • 1. Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA.
    Leliveld SR; Dame RT; Mommaas MA; Koerten HK; Wyman C; Danen-van Oorschot AA; Rohn JL; Noteborn MH; Abrahams JP
    Nucleic Acids Res; 2003 Aug; 31(16):4805-13. PubMed ID: 12907722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptin's functional N- and C-termini independently bind DNA.
    Leliveld SR; Dame RT; Rohn JL; Noteborn MH; Abrahams JP
    FEBS Lett; 2004 Jan; 557(1-3):155-8. PubMed ID: 14741359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptin induces tumor-specific apoptosis as a globular multimer.
    Leliveld SR; Zhang YH; Rohn JL; Noteborn MH; Abrahams JP
    J Biol Chem; 2003 Mar; 278(11):9042-51. PubMed ID: 12496278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral death effector Apoptin reveals tumor-specific processes.
    Rohn JL; Noteborn MH
    Apoptosis; 2004 May; 9(3):315-22. PubMed ID: 15258463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective apoptosis induction in MCF-7 cell line by truncated minimal functional region of Apoptin.
    Shen Ni L; Allaudin ZN; Mohd Lila MA; Othman AM; Othman FB
    BMC Cancer; 2013 Oct; 13():488. PubMed ID: 24144306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptin acts as a tumor-specific killer: potentials for an anti-tumor therapy.
    Noteborn MH
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):49-60. PubMed ID: 16171564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalent conformations and subunit exchange in the biologically active apoptin protein multimer.
    Leliveld SR; Noteborn MH; Abrahams JP
    Eur J Biochem; 2003 Sep; 270(17):3619-27. PubMed ID: 12919326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing.
    Danen-van Oorschot AA; Voskamp P; Seelen MC; van Miltenburg MH; Bolk MW; Tait SW; Boesen-de Cock JG; Rohn JL; Borst J; Noteborn MH
    Cell Death Differ; 2004 May; 11(5):564-73. PubMed ID: 14765135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptin: specific killer of tumor cells?
    Tavassoli M; Guelen L; Luxon BA; Gäken J
    Apoptosis; 2005 Aug; 10(4):717-24. PubMed ID: 16133863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cell-specific fashion.
    Zhang YH; Leliveld SR; Kooistra K; Molenaar C; Rohn JL; Tanke HJ; Abrahams JP; Noteborn MH
    Exp Cell Res; 2003 Sep; 289(1):36-46. PubMed ID: 12941602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of apoptin's 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells.
    Heckl S; Regenbogen M; Sturzu A; Gharabaghi A; Feil G; Beck A; Echner H; Nagele T
    Apoptosis; 2008 Apr; 13(4):495-508. PubMed ID: 18311587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of specific induction of apoptosis in tumor cells by apoptin].
    Wang QM; He FC
    Ai Zheng; 2005 Apr; 24(4):509-12. PubMed ID: 15820081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTD4-apoptin protein therapy inhibits tumor growth in vivo.
    Sun J; Yan Y; Wang XT; Liu XW; Peng DJ; Wang M; Tian J; Zong YQ; Zhang YH; Noteborn MH; Qu S
    Int J Cancer; 2009 Jun; 124(12):2973-81. PubMed ID: 19326452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies.
    Heilman DW; Teodoro JG; Green MR
    J Virol; 2006 Aug; 80(15):7535-45. PubMed ID: 16840333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of apoptin expressed by the dual cancer-specific oncolytic adenovirus - a review.
    Fang JB; Zhu GZ; Zhu YL; Li YQ; Shang C; Bai B; Jin NY; Li X
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11334-11343. PubMed ID: 33215453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallus Heat shock cognate protein 70, a novel binding partner of Apoptin.
    Chen K; Luo Z; Zheng SJ
    Virol J; 2011 Jun; 8():324. PubMed ID: 21707973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected heat shock element binding ability and tumor-killing activity of the combinatorial function domain of apoptin.
    Zhang L; Yang J; Liu L; Tian W; Gao M; Song W; Ling H; Dong X
    Anticancer Drugs; 2017 Apr; 28(4):401-409. PubMed ID: 28045701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptin, a tumor-selective killer.
    Los M; Panigrahi S; Rashedi I; Mandal S; Stetefeld J; Essmann F; Schulze-Osthoff K
    Biochim Biophys Acta; 2009 Aug; 1793(8):1335-42. PubMed ID: 19374922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.
    Maddika S; Panigrahi S; Wiechec E; Wesselborg S; Fischer U; Schulze-Osthoff K; Los M
    Mol Cell Biol; 2009 Mar; 29(5):1235-48. PubMed ID: 19103742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.